Wai Yuen Tong Medicine Holdings Limited (0897.HK)

HKD 0.36

(2.86%)

Revenue Summary of Wai Yuen Tong Medicine Holdings Limited

  • Wai Yuen Tong Medicine Holdings Limited's latest annual revenue in 2023 was 783.88 Million HKD , down -39.07% from previous year.
  • Wai Yuen Tong Medicine Holdings Limited's latest quarterly revenue in 2023 FY was 783.88 Million HKD , down -39.07% from previous quarter.
  • Wai Yuen Tong Medicine Holdings Limited reported a annual revenue of 1.28 Billion HKD in annual revenue 2022, down -7.55% from previous year.
  • Wai Yuen Tong Medicine Holdings Limited reported a annual revenue of 1.39 Billion HKD in annual revenue 2021, up 25.51% from previous year.
  • Wai Yuen Tong Medicine Holdings Limited reported a quarterly revenue of 783.88 Million HKD for 2023 FY, down -39.07% from previous quarter.
  • Wai Yuen Tong Medicine Holdings Limited reported a quarterly revenue of 105.07 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Wai Yuen Tong Medicine Holdings Limited (2023 - 2003)

Historical Annual Revenue of Wai Yuen Tong Medicine Holdings Limited (2023 - 2003)

Year Revenue Revenue Growth
2023 783.88 Million HKD -39.07%
2022 1.28 Billion HKD -7.55%
2021 1.39 Billion HKD 25.51%
2020 1.1 Billion HKD 78.59%
2019 620.74 Million HKD -17.39%
2018 751.44 Million HKD -11.15%
2017 845.78 Million HKD 14.54%
2016 738.44 Million HKD -10.53%
2015 825.33 Million HKD -0.69%
2014 831.08 Million HKD -3.95%
2013 865.25 Million HKD 7.02%
2012 808.51 Million HKD 7.51%
2011 752.07 Million HKD 17.6%
2010 639.51 Million HKD 20.82%
2009 529.3 Million HKD 6.68%
2008 496.15 Million HKD 4.01%
2007 477.02 Million HKD 25.12%
2006 381.26 Million HKD 17.4%
2005 324.75 Million HKD -0.66%
2004 326.9 Million HKD -6.39%
2003 349.22 Million HKD 0.0%

Peer Revenue Comparison of Wai Yuen Tong Medicine Holdings Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -202.472%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 92.555%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -1226.409%
Qianhai Health Holdings Limited 961.29 Million HKD 18.455%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD 25.56%
Essex Bio-Technology Limited 1.7 Billion HKD 54.066%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD 3.118%
PuraPharm Corporation Limited 406.85 Million HKD -92.667%
SSY Group Limited 6.46 Billion HKD 87.871%
JBM (Healthcare) Limited 648.41 Million HKD -20.892%
Jacobson Pharma Corporation Limited 1.46 Billion HKD 46.595%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.71%